10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001213900-22-015012`
Period End Date	20211231
Filing Date	20220325
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	f10k2021_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 22 Cash Flow Statement 50 Stockholders Equity 19

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashEquivalentsAtCarryingValue`	$44.44M	USD	Point-in-time
Cash and cash equivalents	`CashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$114.60M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$167.47M	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$79.46K	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$86.38K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$903.19K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$118.07M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$223.30M	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$1.26K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	$86.38K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$223.33M	USD	Point-in-time
Total assets	`Assets`	$118.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.33M	shares	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.74M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.35M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.19M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.60M	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 27,740,147 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$16.33K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 27,740,147 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$27.74K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$284.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$513.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-305.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-179.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$105.58M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$118.19M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$223.33M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$35.97M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$90.62M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$35.08M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$24.87M	USD	Annual
Total operating expenses	`OperatingExpenses`	$125.70M	USD	Annual
Total operating expenses	`OperatingExpenses`	$60.84M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-125.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-60.84M	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.40M	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.20M	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-156.21K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-636.01K	USD	Annual
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$139.27K	USD	Annual
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-611.38K	USD	Annual
Total other (expenses) income, net	`NonoperatingIncomeExpense`	$-48.32K	USD	Annual
Total other (expenses) income, net	`NonoperatingIncomeExpense`	$1.38M	USD	Annual
Net loss	`NetIncomeLoss`	$-125.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.46M	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-3.81	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-7.16	USD	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.59M	shares	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.55M	shares	Annual

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-125.75M	USD	Annual
Net loss	`ProfitLoss`	$-59.46M	USD	Annual
Depreciation expense	`Depreciation`	$3.75K	USD	Annual
Depreciation expense	`Depreciation`	$1.26K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$40.49M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$20.78M	USD	Annual
Realized loss on short-term investments	`RealizedLossOnShorttermInvestments`	$636.01K	USD	Annual
Realized loss on short-term investments	`RealizedLossOnShorttermInvestments`	$156.21K	USD	Annual
Unrealized loss (gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-139.27K	USD	Annual
Unrealized loss (gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$611.38K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-79.46K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-73.09K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$10.40M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$479.33K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.82M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.85M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.43M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-388.56K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-91.87M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-27.81M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$182.05M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$222.98M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$147.60M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$168.86M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-54.12M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-34.45M	USD	Annual
Principal payments of notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$110.25K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$184.64M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.79M	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$668.43K	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$735.51K	USD	Annual
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$2.63M	USD	Annual
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$8.06M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.47M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$187.94M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-33.78M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$41.95M	USD	Annual
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$36.28M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Interest	`InterestPaidNet`	$2.42K	USD	Annual
Interest	`InterestPaidNet`	-	USD	Annual
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$42.00	USD	Annual
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	-	USD	Annual
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	$90.00	USD	Annual
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	-	USD	Annual

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$40.49M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$20.78M	USD	Annual
ATM offering, net	`ATMOfferingNet`	$23.42M	USD	Annual
Equity offering, net	`EquityOfferingCosts`	$161.23M	USD	Annual
Equity offering, net	`EquityOfferingCosts`	$19.79M	USD	Annual
Warrants exercised	`WarrantExercisedForCash`	$8.06M	USD	Annual
Warrants exercised	`WarrantExercisedForCash`	$2.63M	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	-	USD	Annual
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$735.51K	USD	Annual
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$668.43K	USD	Annual
Cashless exercise of options	`CashlessOptionExercised`	-	USD	Annual
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-125.75M	USD	Annual
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-59.46M	USD	Annual
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.